BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20150308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20151101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20160313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20161106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20161222T120000
DTEND;TZID=America/New_York:20161222T130000
DTSTAMP:20260408T214320
CREATED:20161213T234500Z
LAST-MODIFIED:20190307T201827Z
UID:10000834-1482408000-1482411600@www.med.unc.edu
SUMMARY:Medicine Grand Rounds\, Will Pendergraft "These Are Your Kidneys on Lupus"
DESCRIPTION:Dr. Will Pendergraft is Assistant Professor of Medicine in the Division of Nephrology. His specialty areas include Glomerular disease\, vasculitis (with primary focus on ANCA vasculitis)\, lupus nephritis\, and drug-induced autoimmune disease. \nIn this lecture\, Dr. Pendergraft will describe the impact of lupus on the kidneys and review the current clinical and translational states of lupus nephritis\, including the first successful clinical trial in lupus nephritis. Lupus nephritis is the term used when lupus causes inflammation in the kidneys\, making them unable to properly remove waste from blood or control the amount of fluids in the body. Abnormal levels of waste can build up in the blood and edema can develop. Left untreated\, nephritis can lead to scarring and permanent damage to the kidneys and possibly end-stage renal disease\, requiring dialysis or a kidney transplant. It is estimated that as many as 40 percent of all people with lupus\, and as many as two-thirds of all children with lupus\, will develop kidney complications that require medical evaluation and treatment. \nDr. Pendergraft provides medical care for patients with kidney disease\, educates trainees about nephrology\, and conducts translational and clinical research with a special emphasis on autoimmune diseases that affect the kidneys. His other research interests include: \n\nUnderstanding response to therapy and relapse in lupus nephritis and ANCA vasculitis using high-resolution systems-level tools (epigenetic\, transcriptomic\, metabolomic\, proteomic and microbiomic)\nRepurposing FDA-approved drugs for use in lupus nephritis and ANCA vasculitis\nTranslational studies aimed at understanding drug-induced forms of ANCA vasculitis\nClinical trials of existing and novel biologic therapies for lupus nephritis and ANCA vasculitis\nClinical data analysis of large and unique cohorts of patients with either lupus nephritis\, ANCA vasculitis or idiopathic membranous nephropathy\nIn-depth characterization of rituximab use and development of guidelines to prevent and manage adverse event
URL:https://www.med.unc.edu/medicine/event/dec-22/
CATEGORIES:Medicine Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2019/02/will-pendergraft.jpeg
END:VEVENT
END:VCALENDAR